Misoprostol for Postpartum Hemorrhage:
From Evidence to Action

July 14 & 15  New York City

Misoprostol for Postpartum Hemorrhage: From Evidence to Action showcased a range of rich information on the research, programmatic, and policy efforts underway to promote and use misoprostol for postpartum hemorrhage. Below are the meeting minutes, agenda, and presentations.

Minutes

Agenda

Presentations

Related resources

 

Updates
A key output of the meeting is a set of draft advocacy messages to promote misoprostol’s role in PPH prevention and treatment with a range of audiences at the global, regional, and country levels. These messages will provide a framework for driving policy change and expanding access to misoprostol in the coming years.

Please read Shafia Rashid's blog post about the meeting, in which she shares with a larger audience some of the major themes of our discussions.

The meeting participant list has been updated to facilitate follow-up communication.

Background documents

Contact
Shafia Rashid, Senior Program Officer
Office: +1-646-695-9123
srashid
(at) familycareintl (dot) org

Meeting background
Family Care International (FCI), in collaboration with Gynuity Health Projects, convened individuals and representatives from organizations with an interest in improving access to misoprostol for prevention and treatment of postpartum hemorrhage (PPH).

The meeting brought together key actors, including advocates, programmers, and others, from the maternal and reproductive health community to discuss and develop advocacy strategies for improving access to misoprostol for prevention and treatment of postpartum bleeding. It provided an opportunity to:
1. review key advocacy and policy opportunities and challenges
2. develop evidence-based advocacy and policy strategies
3. draft a set of core messages
4. provide input on a draft advocacy communications strategy

© Family Care International, Inc. 2014. All rights reserved. Our Mission | Privacy Policy | Site Map

spam blockers Get Firefox